Xie Wenqing, Lv Junhao, Wei Chuncun, He Zhechi, Wang Suya
Kidney Disease Center, The First Affiliated Hospital, Zhejiang University, School of Medicine, Hangzhou, China.
Key Laboratory of Kidney Disease Prevention and Control Technology, Hangzhou, China.
Transl Androl Urol. 2025 Feb 28;14(2):402-411. doi: 10.21037/tau-24-398. Epub 2025 Feb 25.
Secondary hyperparathyroidism is an important factor of chronic kidney disease-mineral and bone disorder (CKD-MBD), which frequently results in maintenance dialysis patients having super-high levels of serum intact-parathyroid hormone (iPTH) and bone turnover markers (BTMs). This study aimed to investigate the immediate changes of iPTH and BTMs levels after renal transplantation during the perioperative period, and to explore the allograft function rapid recovery and the effect of high-dose glucocorticoids on serum iPTH and BTMs.
Between April 2018 and August 2021, a total of 346 Chinese kidney transplantation (KT) recipients (median age, 34.0 years; 236 males and 110 females; median dialysis duration, 12 months) were enrolled in this retrospective cohort study. The included patients had been undergoing maintenance dialysis for at least three months before transplant, and all of them accepted short-term high-dose methylprednisolone (MP) to prevent allograft rejection in the perioperative period. Allograft functions were evaluated and divided into different groups accorded to the CKD staging on the postoperative fifth day. Serum beta C-terminal crosslinking telopeptide of type I collagen (β-CTX), type 1N-terminal propeptide (P1NP), osteocalcin (OC), and iPTH were measured from fasting morning blood samples before surgery and on the postoperative fifth day with an electro-chemiluminescence immunoassay analyzer (2012; Roche Diagnostics).
Among the participants, the graft functions were in CKD-II (n=134), CKD-III (n=137), CKD-IV (n=24), and CKD-V (n=51) after the postoperative fifth day. The changes of P1NP level [-95.8 (-84.0 to -2.4) ng/mL] and the OC level [-88.0 (-96.9 to -42.9) ng/mL] were significantly greater than those of the β-CTX level [-62.3 (-73.6 to 0) pg/mL] and the iPTH level [-57.6 (-15.6 to 11.9) pg/mL] (P<0.001). In the CKD-V group, the changes of β-CTX level [-0.7 (-43.15 to 0) pg/mL (+15.7%, P=0.61)] and the iPTH level [-8.69 (226.73 to 17.79) pg/mL (-22.8%), P=0.36] were less than those of the CKD-II group (P<0.001). β-CTX, P1NP, and OC levels related with iPTH (r=0.413, 0.459, 0.482, respectively, P<0.001), and iPTH level with estimated glomerular filtration rate (eGFR; r=-0.474, P<0.001).
The super-high levels of BTMs and iPTH rapidly descended with recuperating allograft function during the short-term, indicating that improvement of current dialysis equipment to achieve clean up iPTH could more favorably decrease BMTs and improve CKD-MBD. Osteogenesis markers P1NP and OC still decreased and were not affected in CKD-V group, indicating that high-dose glucocorticoids might strongly inhibit osteoblast activity.
继发性甲状旁腺功能亢进是慢性肾脏病 - 矿物质和骨异常(CKD - MBD)的一个重要因素,这经常导致维持性透析患者血清全段甲状旁腺激素(iPTH)和骨转换标志物(BTMs)水平超高。本研究旨在调查肾移植围手术期肾移植后iPTH和BTMs水平的即刻变化,并探讨移植肾功能的快速恢复以及大剂量糖皮质激素对血清iPTH和BTMs的影响。
在2018年4月至2021年8月期间,共有346例中国肾移植(KT)受者(中位年龄34.0岁;男性236例,女性110例;中位透析时间12个月)纳入这项回顾性队列研究。纳入的患者在移植前已接受维持性透析至少三个月,并且他们所有人在围手术期均接受短期大剂量甲泼尼龙(MP)以预防移植排斥反应。根据术后第五天的CKD分期评估移植肾功能并将其分为不同组。术前及术后第五天清晨空腹血样采用电化学发光免疫分析仪(2012;罗氏诊断)检测血清I型胶原βC末端交联肽(β - CTX)、I型前胶原N端前肽(P1NP)、骨钙素(OC)和iPTH。
参与者中,术后第五天移植肾功能处于CKD - II期(n = 134)、CKD - III期(n = 137)、CKD - IV期(n = 24)和CKD - V期(n = 51)。P1NP水平的变化[-95.8(-84.0至-2.4)ng/mL]和OC水平的变化[-88.0(-96.9至-42.9)ng/mL]显著大于β - CTX水平的变化[-62.3(-73.6至0)pg/mL]和iPTH水平的变化[-57.6(-15.6至11.9)pg/mL](P < 0.001)。在CKD - V组中,β - CTX水平的变化[-0.7(-43.15至0)pg/mL(+15.7%,P = 0.61)]和iPTH水平的变化[-8.69(226.73至17.79)pg/mL(-22.8%),P = 0.36]小于CKD - II组(P < 0.001)。β - CTX、P1NP和OC水平与iPTH相关(r分别为0.413、0.459、0.482,P < 0.001),iPTH水平与估计肾小球滤过率(eGFR;r = -0.474,P < 0.001)相关。
在短期内,随着移植肾功能的恢复,超高水平的BTMs和iPTH迅速下降,这表明改进当前的透析设备以清除iPTH可能更有利于降低BMTs并改善CKD - MBD。成骨标志物P1NP和OC在CKD - V组中仍下降且未受影响,表明大剂量糖皮质激素可能强烈抑制成骨细胞活性。